Skip to main content

Table 5 Total tumour burden repeatability for different tracer uptake intervals, reconstruction settings, and lesion delineation methods

From: Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients

Method

60 min of uptake

90 min of uptake

TRT (RC)

TRT% (RC%)

ICC

TRT (RC)

TRT% (RC%)

ICC

EARL

 SUV25

322 (1560)

5.8 (56)

0.95

59 (319)

4.0 (18)

1.00

 SUV40

236 (1149)

3.7 (54)

0.97

38 (252)

8.4 (34)

1.00

 41MAX

122 (611)

8.9 (47)

0.93

59 (169)

3.1 (11)

1.00

 A50P

126 (667)

7.6 (56)

0.90

92 (287)

9.7 (36)

0.99

 MV2

257 (1133)

9.4 (54)

0.97

44 (257)

4.1 (21)

1.00

 MV3

96 (633)

3.7 (48)

0.93

91 (282)

8.4 (35)

0.99

 RD

41 (505)

− 4.6 (43)

0.99

 

PSF

 SUV25

309 (1069)

9.1 (45)

0.98

462 (2490)

10.0 (41)

0.93

 SUV40

133 (780)

1.2 (39)

0.99

41 (260)

6.3 (26)

1.00

 41MAX

65 (326)

3.1 (38)

0.98

83 (272)

5.9 (22)

0.99

 A50P

60 (355)

− 1.2 (32)

0.97

64 (182)

8.6 (28)

1.00

 MV2

138 (778)

1.4 (42)

0.99

70 (333)

5.7 (24)

1.00

 MV3

62 (322)

0.8 (28)

0.98

44 (115)

4.5 (17)

1.00

  1. Average and repeatability coefficient of total tumour burden (TTB) repeatability for different tracer uptake intervals, reconstruction settings, and lesion delineation methods including the corresponding ICC. TRT in mL and TRT% in percentage